Skip to main content

Find Clinical Trials

Home
Conditions
Hepatitis C Virus

Clinical trial condition

Hepatitis C Virus

Explore clinical trials studying Hepatitis C Virus. Study availability and eligibility vary by location and protocol.

85 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Hepatitis C Virus trial results

Completed

Sofosbuvir in Combination With Pegylated Interferon and Ribavirin and in Treatment-Naive Hepatitis C-infected Patients

NCT01188772

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Alabama Liver and Digestive Specialists Montgomery, Alabama, United States

Advanced Clinical Research Institute Anaheim, California, United States

SCTI Research Foundation Coronado, California, United States

Cedars Sinai Medical Center Los Angeles, California, United States

View all 23 locations

View Trial Details

Completed

Phase 1 Study To Evaluate Antiviral Activity Of Small Molecule Direct Antiviral Agent At Multiple Doses In Subjects With Chronically Infected Hepatitis C Virus.

NCT00671671

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Pfizer Investigational Site Gainesville, Florida, United States

View Trial Details

Completed

TMC435-TiDP16-C113: A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics of TMC435

NCT01046058

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Anaheim, California, United States

Orlando, Florida, United States

San Antonio, Texas, United States

View Trial Details

Completed

TMC435-TiDP16-C126 - Trial to Investigate the Effect of Severe Renal Impairment on the Pharmacokinetics and Safety of TMC435

NCT01381835

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Prague, Czechia

View Trial Details

Completed

Hepatitis C Virus and the Humoral Immune System

NCT00219999

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Rockefeller University Hosital New York, United States

View Trial Details

Completed

TMC435-TiDP16-C125 - Study in Healthy Volunteers to Evaluate the Potential of TMC435 to Increase the Sensitivity of the Skin Towards Exposure to Sun Light

NCT01124799

Conditions: Blood-Borne Infections, Communicable Diseases, Dermatitis, +17 more
Locations: Not specified

View Trial Details

Completed

TMC435-TiDP16-C119 - A Study Comparing 2 New Capsule Formulations of TMC435 to an Established Capsule Formulation and Evaluating the Respective Blood Levels of TMC435 Following Single Dose Administration

NCT01134718

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Not specified

View Trial Details

Completed

TMC435-TiDP16-C112 - Interaction Trial With Antidepressants

NCT01090700

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Not specified

View Trial Details

Completed

A Study in Healthy Female Participants Investigating the Effect of TMC435 on the Pharmacokinetics of the Synthetic Hormones of the Oral Contraceptive Ovysmen

NCT01486004

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Merksem, Belgium

View Trial Details

Completed

TMC435-TiDP16-C108 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and Digoxin and Between TMC435 and Rosuvastatin

NCT01288742

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Not specified

View Trial Details